In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme.
Mol Ther Oncolytics
; 26: 289-301, 2022 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-36090479
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2022
Type:
Article
Affiliation country:
United States